Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Marfan Syndrome | 3 | 2022 | 42 | 0.480 |
Why?
|
Heart Defects, Congenital | 6 | 2009 | 596 | 0.420 |
Why?
|
Ultrasonography, Prenatal | 2 | 2009 | 79 | 0.320 |
Why?
|
Atenolol | 2 | 2020 | 20 | 0.300 |
Why?
|
Losartan | 2 | 2020 | 45 | 0.290 |
Why?
|
Cardiac Surgical Procedures | 5 | 2010 | 450 | 0.250 |
Why?
|
Echocardiography | 2 | 2009 | 515 | 0.210 |
Why?
|
Ectopia Lentis | 1 | 2022 | 4 | 0.210 |
Why?
|
Cytochrome P-450 CYP2C9 | 1 | 2020 | 5 | 0.190 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2020 | 7 | 0.190 |
Why?
|
Matrix Metalloproteinases | 2 | 2010 | 223 | 0.160 |
Why?
|
Pulmonary Artery | 2 | 2013 | 323 | 0.160 |
Why?
|
Myxoma | 1 | 2015 | 17 | 0.130 |
Why?
|
Heart Neoplasms | 1 | 2015 | 33 | 0.130 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 1293 | 0.120 |
Why?
|
Arteriovenous Malformations | 1 | 2013 | 34 | 0.110 |
Why?
|
Exercise Test | 1 | 2014 | 242 | 0.110 |
Why?
|
Child | 7 | 2022 | 6401 | 0.110 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2013 | 134 | 0.100 |
Why?
|
Endothelium, Vascular | 1 | 2013 | 371 | 0.100 |
Why?
|
Infant | 6 | 2020 | 2891 | 0.100 |
Why?
|
Heart Ventricles | 1 | 2015 | 738 | 0.100 |
Why?
|
Miniaturization | 1 | 2010 | 21 | 0.090 |
Why?
|
Heart Septal Defects | 1 | 2010 | 27 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2013 | 384 | 0.090 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 85 | 0.090 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2010 | 106 | 0.090 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2009 | 25 | 0.090 |
Why?
|
Echocardiography, Transesophageal | 1 | 2010 | 100 | 0.090 |
Why?
|
Chromosome Aberrations | 1 | 2009 | 86 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 1 | 2009 | 99 | 0.080 |
Why?
|
Genotype | 2 | 2022 | 785 | 0.080 |
Why?
|
Wounds, Nonpenetrating | 1 | 2009 | 131 | 0.080 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2008 | 99 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 2008 | 109 | 0.080 |
Why?
|
Cardiopulmonary Bypass | 1 | 2009 | 250 | 0.080 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 2 | 2020 | 7 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2010 | 493 | 0.070 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2020 | 95 | 0.070 |
Why?
|
Parents | 1 | 2009 | 309 | 0.070 |
Why?
|
Decision Making | 1 | 2009 | 410 | 0.070 |
Why?
|
Humans | 15 | 2022 | 68549 | 0.070 |
Why?
|
Aspirin | 1 | 2007 | 295 | 0.070 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2006 | 72 | 0.060 |
Why?
|
Pregnancy | 3 | 2009 | 2334 | 0.060 |
Why?
|
Heart Arrest | 1 | 2006 | 113 | 0.060 |
Why?
|
Phenotype | 2 | 2022 | 946 | 0.060 |
Why?
|
Palliative Care | 1 | 2007 | 271 | 0.060 |
Why?
|
Myocardium | 1 | 2010 | 1204 | 0.060 |
Why?
|
Adolescent | 5 | 2020 | 8904 | 0.060 |
Why?
|
Child, Preschool | 3 | 2020 | 3187 | 0.060 |
Why?
|
Female | 9 | 2020 | 38021 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2020 | 3256 | 0.060 |
Why?
|
Fetal Diseases | 1 | 2004 | 64 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2020 | 7268 | 0.050 |
Why?
|
Mass Screening | 1 | 2008 | 838 | 0.050 |
Why?
|
Infant, Newborn | 4 | 2010 | 2455 | 0.050 |
Why?
|
Fibrillins | 1 | 2022 | 24 | 0.050 |
Why?
|
Fibrillin-1 | 1 | 2022 | 18 | 0.050 |
Why?
|
Biological Variation, Population | 1 | 2022 | 8 | 0.050 |
Why?
|
Ultrasonography | 2 | 2015 | 453 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2004 | 1465 | 0.050 |
Why?
|
Anastomosis, Surgical | 2 | 2013 | 104 | 0.040 |
Why?
|
Male | 7 | 2020 | 37283 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 5710 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2014 | 1046 | 0.040 |
Why?
|
DNA | 1 | 2020 | 597 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 1213 | 0.030 |
Why?
|
Cytokines | 2 | 2010 | 866 | 0.030 |
Why?
|
Adult | 4 | 2020 | 21379 | 0.030 |
Why?
|
Anaerobic Threshold | 1 | 2014 | 13 | 0.030 |
Why?
|
Postoperative Period | 1 | 2014 | 238 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2014 | 258 | 0.030 |
Why?
|
Incidence | 2 | 2008 | 1582 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2013 | 7028 | 0.030 |
Why?
|
Fontan Procedure | 1 | 2014 | 129 | 0.030 |
Why?
|
Linear Models | 1 | 2014 | 521 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2013 | 168 | 0.030 |
Why?
|
Swine | 1 | 2013 | 672 | 0.020 |
Why?
|
Prospective Studies | 2 | 2010 | 3703 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2010 | 84 | 0.020 |
Why?
|
Amniocentesis | 1 | 2009 | 12 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 238 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 306 | 0.020 |
Why?
|
Maternal Age | 1 | 2009 | 70 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2009 | 242 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 546 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2008 | 32 | 0.020 |
Why?
|
Equipment Design | 1 | 2010 | 500 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2009 | 109 | 0.020 |
Why?
|
Cardiology | 1 | 2009 | 140 | 0.020 |
Why?
|
Odds Ratio | 1 | 2009 | 880 | 0.020 |
Why?
|
Recovery of Function | 1 | 2009 | 506 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2013 | 2550 | 0.020 |
Why?
|
Logistic Models | 1 | 2009 | 1419 | 0.020 |
Why?
|
Biomarkers | 1 | 2010 | 1593 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 2004 | 73 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2004 | 157 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2008 | 2077 | 0.010 |
Why?
|
South Carolina | 1 | 2008 | 2752 | 0.010 |
Why?
|
Survival Rate | 1 | 2004 | 1055 | 0.010 |
Why?
|
Risk Factors | 1 | 2009 | 5720 | 0.010 |
Why?
|
Prognosis | 1 | 2004 | 2093 | 0.010 |
Why?
|
Animals | 1 | 2013 | 20880 | 0.010 |
Why?
|
Aged | 1 | 2010 | 14842 | 0.010 |
Why?
|
Middle Aged | 1 | 2010 | 21119 | 0.010 |
Why?
|